Previous reports have shown that MIP-1β is produced in response to brain damage and activates immunological cells (neutrophils, microglia, and astroglia) to induce neuroinflammatory processes in neurological disorders (Howes et al., 2014). This evidence concerns the gene CCL4 and nervous system disorder.